Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on CNS Drug Development. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN118666833B reveals a high-yield 90% synthesis route for 2-(5-bromopyridin-3-yl)quinuclidine, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN110746340A reveals a high-yield synthesis of 5-methoxy-2-methyltryptamine via nitroethane condensation. Offers cost-effective scaling for pharmaceutical intermediates.